Oscar Health ($OSCR): Navigating Transformative Growth with Impressive Q2 Projections
Oscar Health, Inc. (OSCR) is poised for a remarkable Q2, forecasting a 29.9% boost in revenue, an 80% surge in EBIT, and an impressive 111% rise in EPS. As the...
Event Watch
248 results found
Rocket Lab $RKLB Joins the $IWB Russell 1000: A New...
Rocket Lab USA's entry into the iShares Russell 1000 ETF marks a milestone, highlighting its growing stature among large-cap growth stocks. This inclusion is a potential catalyst for increased institutional...
Myrtle Beach Golf Empire: $FGI Investment Thesis – Fairway to...
Founders Group International dominates Myrtle Beach's golf scene with 22 courses and a clever vertically integrated model. Although privately owned, their estimated 25% market share and initiatives like "Kids Play...
Rocket Lab ($RKLB) Reaches New Heights with 10th Electron Launch...
Rocket Lab has achieved its 10th successful Electron launch in 2025, marking a strategic milestone in the small satellite launch market. The Symphony in the Stars mission, executed with precise...
Is This Biotech Giant a Hidden Gem or Mispriced Puzzle?...
A biotech titan, renowned for its mRNA innovation, might just be undervalued at a price nearly equivalent to its cash reserves. With $2 billion in COVID-19 vaccine revenues and over...
Tesla’s First Unsupervised Delivery: A Bold Step in Autonomous Driving
Tesla has successfully completed its first unsupervised Full Self-Driving delivery, navigating a vehicle from the factory directly to a customer in Austin, Texas. This pivotal milestone could significantly enhance operational...
$TNXP Investment Thesis: A Compelling Asymmetric Opportunity in Fibromyalgia Treatment
Tonix Pharmaceuticals offers a unique investment opportunity with its leading candidate, TNX-102 SL, poised to disrupt the $2.1 billion fibromyalgia market. Sporting a robust cash position and no debt, the...
Goldman Sachs Increases Stake in $HIMS: A Bold Play in...
Goldman Sachs' audacious move to increase its stake in Hims & Hers Health by 45% positions itself as a significant player in the dynamic realm of telehealth. Holding over 8...
Zeta Global $ZETA: Buyout Buzz and Bullish Sentiments on the...
Rumours are swirling around Zeta Global Holdings as potential buyers eye its AI-driven marketing tech prowess. With a 36% revenue increase in Q1 2025 and the sector ripe for acquisitions,...
AbCellera Biologics ($ABCL) Investment Thesis: Riding the AI Drug Discovery...
AbCellera Biologics Inc. (ABCL) emerges as a notable player in the AI-driven drug discovery realm, targeting a 12-month price of $17.00, a potential leap from the current valuation. This optimism...
